RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BMRN
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for BioMarin Pharmaceutical Inc. stock after losing 0.501%
(Updated on May 24, 2024)

Sell candidate since Apr 30, 2024 Loss -6.49% PDF

The BioMarin Pharmaceutical Inc. stock price fell by -0.501% on the last day (Friday, 24th May 2024) from $75.90 to $75.52. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 1.12% from a day low at $75.12 to a day high of $75.96. The price has fallen in 7 of the last 10 days and is down by -6.8% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -883 thousand shares and in total, 873 thousand shares were bought and sold for approximately $65.93 million.

The stock has broken the wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($76.92) are considered to be a "second chance" to get out. According to the fan-theory $65.93 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BMRN Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The BioMarin Pharmaceutical Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $76.68 and $83.90. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, April 12, 2024, and so far it has fallen -18.11%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for BioMarin Pharmaceutical Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.84 between high and low, or 1.12%. For the last week, the stock has had daily average volatility of 1.67%.

BioMarin Pharmaceutical Inc. is oversold on RSI14 (20). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BMRN) For The Upcoming Trading Day Of Tuesday 28th

For the upcoming trading day on Tuesday, 28th we expect BioMarin Pharmaceutical Inc. to open at $75.53, and during the day (based on 14 day Average True Range), to move between $73.67 and $77.37, which gives a possible trading interval of +/-$1.85 (+/-2.45%) up or down from last closing price. If BioMarin Pharmaceutical Inc. takes out the full calculated possible swing range there will be an estimated 4.91% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $76.97, some $1.45 (1.92%) from the current price of $75.52, our system finds the risk reward not very attractive.

Is BioMarin Pharmaceutical Inc. stock A Buy?

BioMarin Pharmaceutical Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.547 Sell Candidate Unchanged

Predicted Opening Price for BioMarin Pharmaceutical Inc. of Tuesday, May 28, 2024

Fair opening price May 28, 2024 Current price
$75.53 ( 0.0177%) $75.52

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BMRN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 76.37 1.13 %
R2 76.05 0.705 %
R1 75.85 0.443 %
Current price: 75.52
Support S1 75.21 -0.407 %
S2 75.01 -0.670 %
S3 74.69 -1.09 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 82.17 8.81 %
R2 77.56 2.70 %
R1 76.97 1.92 %
Current price 75.52
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for BioMarin Pharmaceutical Inc. Stock and on which exchange is it traded?
The symbol for BioMarin Pharmaceutical Inc. is BMRN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioMarin Pharmaceutical Inc. Stock?
BioMarin Pharmaceutical Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy BioMarin Pharmaceutical Inc. Stock?
BioMarin Pharmaceutical Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioMarin Pharmaceutical Inc. Stock.

What's the current price of BioMarin Pharmaceutical Inc. Stock?
As of the end of day on the May 24, 2024, the price of an BioMarin Pharmaceutical Inc. (BMRN) share was $75.52.

What is the 52-week high and low for BioMarin Pharmaceutical Inc. Stock?
The 52-week high for BioMarin Pharmaceutical Inc. Stock is $99.55 and the 52-week low is $75.03.

What is the market capitalization of BioMarin Pharmaceutical Inc. Stock?
As of the May 24, 2024, the market capitalization of BioMarin Pharmaceutical Inc. is 14.34B.

When is the next earnings date for BioMarin Pharmaceutical Inc.?
The upcoming earnings date for BioMarin Pharmaceutical Inc. is Jul 29, 2024.
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT